Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


Articles published in Mol Psychiatry

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    November 2018
  1. COLLIN G, Seidman LJ, Keshavan MS, Stone WS, et al
    Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program.
    Mol Psychiatry. 2018 Nov 8. pii: 10.1038/s41380-018-0288.
    PubMed     Text format     Abstract available


    October 2018
  2. PILLINGER T, D'Ambrosio E, McCutcheon R, Howes OD, et al
    Correction to: Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models.
    Mol Psychiatry. 2018 Oct 18. pii: 10.1038/s41380-018-0275.
    PubMed     Text format     Abstract available


  3. DOUCET GE, Moser DA, Luber MJ, Leibu E, et al
    Baseline brain structural and functional predictors of clinical outcome in the early course of schizophrenia.
    Mol Psychiatry. 2018 Oct 3. pii: 10.1038/s41380-018-0269.
    PubMed     Text format     Abstract available


    September 2018
  4. GUO JY, Ragland JD, Carter CS
    Memory and cognition in schizophrenia.
    Mol Psychiatry. 2018 Sep 21. pii: 10.1038/s41380-018-0231.
    PubMed     Text format     Abstract available


  5. WANG HY, MacDonald ML, Borgmann-Winter KE, Banerjee A, et al
    mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia.
    Mol Psychiatry. 2018 Sep 13. pii: 10.1038/s41380-018-0234.
    PubMed     Text format     Abstract available


  6. CAI HQ, Catts VS, Webster MJ, Galletly C, et al
    Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation.
    Mol Psychiatry. 2018 Sep 13. pii: 10.1038/s41380-018-0235.
    PubMed     Text format     Abstract available


    August 2018
  7. ORLOVSKA-WAAST S, Kohler-Forsberg O, Brix SW, Nordentoft M, et al
    Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
    Mol Psychiatry. 2018 Aug 16. pii: 10.1038/s41380-018-0220.
    PubMed     Text format     Abstract available


    July 2018
  8. SEGEV A, Yanagi M, Scott D, Southcott SA, et al
    Reduced GluN1 in mouse dentate gyrus is associated with CA3 hyperactivity and psychosis-like behaviors.
    Mol Psychiatry. 2018 Jul 23. pii: 10.1038/s41380-018-0124.
    PubMed     Text format     Abstract available


    June 2018
  9. KUMAR J, Liddle EB, Fernandes CC, Palaniyappan L, et al
    Glutathione and glutamate in schizophrenia: a 7T MRS study.
    Mol Psychiatry. 2018 Jun 22. pii: 10.1038/s41380-018-0104.
    PubMed     Text format     Abstract available


  10. CAO B, Cho RY, Chen D, Xiu M, et al
    Treatment response prediction and individualized identification of first-episode drug-naive schizophrenia using brain functional connectivity.
    Mol Psychiatry. 2018 Jun 19. pii: 10.1038/s41380-018-0106.
    PubMed     Text format     Abstract available


  11. SUN D, Ching CRK, Lin A, Forsyth JK, et al
    Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
    Mol Psychiatry. 2018 Jun 13. pii: 10.1038/s41380-018-0078.
    PubMed     Text format     Abstract available


  12. CHAUMETTE B, Ferrafiat V, Ambalavanan A, Goldenberg A, et al
    Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia.
    Mol Psychiatry. 2018 Jun 12. pii: 10.1038/s41380-018-0103.
    PubMed     Text format     Abstract available


  13. EGERTON A, Broberg BV, Van Haren N, Merritt K, et al
    Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre (1)H-MRS study (OPTiMiSE).
    Mol Psychiatry. 2018 Jun 7. pii: 10.1038/s41380-018-0082.
    PubMed     Text format     Abstract available


    May 2018
  14. PILLINGER T, D'Ambrosio E, McCutcheon R, D Howes O, et al
    Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models.
    Mol Psychiatry. 2018 May 9. pii: 10.1038/s41380-018-0058.
    PubMed     Text format     Abstract available


  15. HAUBERG ME, Fullard JF, Zhu L, Cohain AT, et al
    Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls.
    Mol Psychiatry. 2018 May 8. pii: 10.1038/s41380-018-0059.
    PubMed     Text format     Abstract available


    April 2018
  16. JAUHAR S, Veronese M, Nour MM, Rogdaki M, et al
    Determinants of treatment response in first-episode psychosis: an (18)F-DOPA PET study.
    Mol Psychiatry. 2018 Apr 20. pii: 10.1038/s41380-018-0042.
    PubMed     Text format     Abstract available


    March 2018
  17. CHOUINARD VA, Henderson DC, Dalla Man C, Valeri L, et al
    Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis.
    Mol Psychiatry. 2018 Mar 9. pii: 10.1038/s41380-018-0045.
    PubMed     Text format     Abstract available


  18. OSIMO EF, Beck K, Reis Marques T, Howes OD, et al
    Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
    Mol Psychiatry. 2018 Mar 6. pii: 10.1038/s41380-018-0041.
    PubMed     Text format     Abstract available


  19. SULLIVAN CR, Koene RH, Hasselfeld K, O'Donovan SM, et al
    Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia.
    Mol Psychiatry. 2018 Mar 1. pii: 10.1038/s41380-018-0035.
    PubMed     Text format     Abstract available


    February 2018
  20. KIM DD, Barr AM, Honer WG, Procyshyn RM, et al
    Exercise-induced hippocampal neurogenesis: 5-HT3 receptor antagonism by antipsychotics as a potential limiting factor in Schizophrenia.
    Mol Psychiatry. 2018 Feb 8. pii: 10.1038/s41380-018-0022.
    PubMed     Text format    


    January 2018
  21. LIEBERMAN JA, Girgis RR, Brucato G, Moore H, et al
    Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.
    Mol Psychiatry. 2018 Jan 9. pii: mp2017249. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  22. DE VRIJ FM, Bouwkamp CG, Gunhanlar N, Shpak G, et al
    Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia.
    Mol Psychiatry. 2018 Jan 4. pii: 10.1038/s41380-017-0004.
    PubMed     Text format     Abstract available


    November 2017
  23. STEULLET P, Cabungcal JH, Bukhari SA, Ardelt MI, et al
    The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress.
    Mol Psychiatry. 2017 Nov 28. pii: mp2017230. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  24. CHENG CM, Chang WH, Chen MH, Tsai CF, et al
    Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study.
    Mol Psychiatry. 2017 Nov 7. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  25. ENWRIGHT III JF, Huo Z, Arion D, Corradi JP, et al
    Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia.
    Mol Psychiatry. 2017 Nov 7. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  26. KENDLER KS
    The genealogy of major depression: symptoms and signs of melancholia from 1880 to 1900.
    Mol Psychiatry. 2017;22:1539-1553.
    PubMed     Text format     Abstract available


    October 2017
  27. KELLY S, Jahanshad N, Zalesky A, Kochunov P, et al
    Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.
    Mol Psychiatry. 2017 Oct 17. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  28. GREENE C, Kealy J, Humphries MM, Gong Y, et al
    Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia.
    Mol Psychiatry. 2017 Oct 10. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  29. LEGGE SE, Hamshere ML, Ripke S, Pardinas AF, et al
    Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia.
    Mol Psychiatry. 2017;22:1502-1508.
    PubMed     Text format     Abstract available


    September 2017
  30. ZHOU Y, Dong F, Lanz TA, Reinhart V, et al
    Interactome analysis reveals ZNF804A, a schizophrenia risk gene, as a novel component of protein translational machinery critical for embryonic neurodevelopment.
    Mol Psychiatry. 2017 Sep 19. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  31. SOLIMAN MA, Aboharb F, Zeltner N, Studer L, et al
    Pluripotent stem cells in neuropsychiatric disorders.
    Mol Psychiatry. 2017;22:1241-1249.
    PubMed     Text format     Abstract available


    August 2017
  32. ALACHKAR A, Wang L, Yoshimura R, Hamzeh AR, et al
    Prenatal one-carbon metabolism dysregulation programs schizophrenia-like deficits.
    Mol Psychiatry. 2017 Aug 15. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  33. GUR RE, Bassett AS, McDonald-McGinn DM, Bearden CE, et al
    A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.
    Mol Psychiatry. 2017 Aug 1. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  34. NIMGAONKAR VL, Prasad KM, Chowdari KV, Severance EG, et al
    The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.
    Mol Psychiatry. 2017 Aug 1. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    July 2017
  35. WEINSTEIN JJ, van de Giessen E, Rosengard RJ, Xu X, et al
    PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Mol Psychiatry. 2017 Jul 25. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  36. BENAMER N, Marti F, Lujan R, Hepp R, et al
    GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons.
    Mol Psychiatry. 2017 Jul 11. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  37. RAO AR, Yourshaw M, Christensen B, Nelson SF, et al
    Rare deleterious mutations are associated with disease in bipolar disorder families.
    Mol Psychiatry. 2017;22:1009-1014.
    PubMed     Text format     Abstract available


    June 2017
  38. TENG S, Thomson PA, McCarthy S, Kramer M, et al
    Rare disruptive variants in the DISC1 Interactome and Regulome: association with cognitive ability and schizophrenia.
    Mol Psychiatry. 2017 Jun 20. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    May 2017
  39. KIM Y, Giusti-Rodriguez P, Crowley JJ, Bryois J, et al
    Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects.
    Mol Psychiatry. 2017 May 30. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  40. WEINSTEIN JJ, van de Giessen E, Rosengard RJ, Xu X, et al
    PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Mol Psychiatry. 2017 May 16. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  41. MOBERGET T, Doan NT, Alnaes D, Kaufmann T, et al
    Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls.
    Mol Psychiatry. 2017 May 16. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  42. BIRNBAUM R, Jaffe AE, Chen Q, Shin JH, et al
    Investigating the neuroimmunogenic architecture of schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  43. TAO R, Davis KN, Li C, Shin JH, et al
    GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  44. DEMICHELE-SWEET MAA, Weamer EA, Klei L, Vrana DT, et al
    Genetic risk for schizophrenia and psychosis in Alzheimer disease.
    Mol Psychiatry. 2017 May 2. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    April 2017
  45. DUNCAN LE, Ratanatharathorn A, Aiello AE, Almli LM, et al
    Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.
    Mol Psychiatry. 2017 Apr 25. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  46. HADAR R, Bikovski L, Soto-Montenegro ML, Schimke J, et al
    Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia.
    Mol Psychiatry. 2017 Apr 4. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    March 2017
  47. NOTTER T, Meyer U
    Microglia and schizophrenia: where next?
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format    


  48. PARKER KL, Kim YC, Kelley RM, Nessler AJ, et al
    Delta-frequency stimulation of cerebellar projections can compensate for schizophrenia-related medial frontal dysfunction.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  49. LYALL AE, Pasternak O, Robinson DG, Newell D, et al
    Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  50. DEVOR A, Andreassen OA, Wang Y, Maki-Marttunen T, et al
    Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  51. STEULLET P, Cabungcal JH, Coyle J, Didriksen M, et al
    Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia.
    Mol Psychiatry. 2017 Mar 21. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  52. WESSELING H, Xu B, Want EJ, Holmes E, et al
    System-based proteomic and metabonomic analysis of the Df(16)A+/- mouse identifies potential miR-185 targets and molecular pathway alterations.
    Mol Psychiatry. 2017;22:384-395.
    PubMed     Text format     Abstract available


    January 2017
  53. WEBER-STADLBAUER U, Richetto J, Labouesse MA, Bohacek J, et al
    Transgenerational transmission and modification of pathological traits induced by prenatal immune activation.
    Mol Psychiatry. 2017;22:102-112.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: